PRCT Q2 2022 Earnings — PROCEPT BioRobotics Corporation Revenue & Financial Results | Market Cap Arena

PRCTPROCEPT BioRobotics Corporation

$1B

Q2 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$17M+96.9% YoY

Gross Profit

$8M50.8% margin

Operating Income

-$18M-107.1% margin

Net Income

-$19M-114.9% margin

EPS (Diluted)

$-0.43

QoQ Revenue Growth

+17.6%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$17M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$311M

Total Liabilities

$72M

Stockholders' Equity

$239M

Cash & Equivalents

$270M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17M	$8M	+96.9%
Gross Profit	$8M	$4M	+136.8%
Operating Income	-$18M	-$13M	-35.5%
Net Income	-$19M	-$15M	-31.6%

Geographic Segments

UNITED STATES

$9M91%

Outside the United States

$869,0009%